Administering compositions for improved immune system functioning
The present disclosure relates to methods of administering a composition to a patient, particularly in the form of a dietary supplement, which addresses immune system deficiencies and promotes healthy immune system functioning. The present disclosure also related to compositions and methods for improving or boosting immune system functioning. The present disclosure further provides novel compositions for balancing immune response in human subjects.
1. A method of treating a patient with an immune system deficiency, comprising:
administering to the patient with a capsule, wherein the capsule comprises:
from about 250 to 750 mcg of Yeast Fermentate;
from about 100 to 300 mg the Olive Leaf Extract; and
from about 100 to 300 mg of Andrographis Extract;
from about 100 to 300 mg N-acetylcysteine;
from about 50 to 150 mg Skullcap Root Extract; and
from about 12.5 to 200 mg Trans-Resveratrol,
wherein the immune system deficiency is Hashimoto's disease.
2. The method of claim 1 , wherein the composition is administered to the patient in the form of a dietary supplement.
3. The method of claim 1 , wherein the composition is administered to the patient in the form of an acid resistant capsule.
4. The method of claim 1 , wherein the composition is administered orally in the form of a tablet.
5. The method of claim 1 , wherein the composition administered to the patient further comprises a palatability agent.
6. The method of claim 5 , wherein the palatability agent is at least one of a plant oil, plant hydrolysates, yeast, and yeast hydrolysates, and combinations thereof.
7. The method of claim 1 , wherein the composition administered to the patient does not include milk, casein, gluten, wheat, eggs, peanuts, tree nuts, dairy, corn, soybeans, sugar and fish/shellfish.
8. The method of claim 1 , wherein the Trans-resveratrol is provided in the form of Polygonum cuspidatum.
9. A method of improving immune system functioning in a patient exhibiting disorders relating to the same, wherein the method comprises administering a composition consisting essentially of:
500 mg of Dried Yeast Fermentate;
200 mcg of Olive Leaf Extract;
200 mg of Andrographis Extract;
200 mg of N-acetylcysteine;
100 mg of Skullcap Root Extract; and
25 mg of Trans-Resveratrol;
wherein the patient is exhibiting Hashimoto's disease.
10. The method of claim 9 , wherein the Trans-Resveratrol is selected from 50 mg Polygonum cuspidatum.
11. The method of claim 9 , wherein the composition administered to the patient is devoid of the following: milk, casein, gluten, wheat, eggs, peanuts, tree nuts, dairy, corn, soybeans, sugar and fish/shellfish.
12. The method of claim 9 , wherein the composition is administered to the patient in the form of a dietary supplement.
13. The method of claim 9 , wherein the composition is administered to the patient in the form of an acid resistant capsule.
14. The method of claim 9 , wherein the composition is administered orally in the form of a tablet.
15. The method of claim 9 , wherein the composition further comprises at least one palatability agent.
16. The method of claim 15 , wherein the palatability agent is at least one of a plant oil, plant hydrolysates, yeast, and yeast hydrolysates, and combinations thereof.